Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: EISANA CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-11 to 2025-03-10
Current total value of award: $399824
Description: TOPIC 447: DEVELOPMENT AND TESTING OF A NON-INVASIVE CRYO-DEVICE TO PREVENT CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN HANDS AND FEET OF CANCER PATIENTS RECEIVING TAXOL FOR BREAST CANCER.